Huntington's disease, an inherited neurodegenerative disorder, results from abnormal polyglutamine extension in the N-terminal region of the huntingtin protein. This mutation causes preferential degeneration of striatal projection neurons. We previously demonstrated, in vitro, that dopaminergic D2 receptor stimulation acted in synergy with expanded huntingtin to increase aggregates formation and striatal death through activation of the Rho/ROCK signaling pathway. In vivo, in a lentiviral-mediated model of expanded huntingtin expression in the rat striatum, we found that the D2 antagonist haloperidol protects striatal neurons against expanded huntingtin-mediated toxicity. Two variant transcripts are generated by alternative splicing of the of D2 receptor gene, the D2R-Long and the D2R-Short, which are thought to play different functional roles. We show herein that overexpression of D2R-Short, but not D2R-Long in cell lines is associated with activation of the RhoA/ROCK signaling pathway. In striatal neurons in culture, the selective D2 agonist Quinpirole triggers phosphorylation of cofilin, a downstream effector of ROCK, which is abrogated by siRNAs that knockdown both D2R-Long and D2R-Short, but not by siRNAs targeting D2R-Long alone. Aggregate formation and neuronal death induced by expanded huntingtin, were potentiated by Quinpirole. This D2 agonist-mediated effect was selectively inhibited by the siRNA targeting both D2R-Long and D2R-Short but not D2R-Long alone. Our data provide evidence for a specific coupling of D2R-Short to the RhoA/ROCK/cofilin pathway, and its involvement in striatal vulnerability to expanded huntingtin. A new route for targeting Rho-ROCK signaling in Huntington's disease is unraveled with our findings.
Introduction
Huntington's disease (HD) is an inherited neurodegenerative disorder resulting from abnormal polyglutamine extension in the N-terminal region of the huntingtin protein (Exp-HTT; The Huntington's Disease Collaboration Group, 1993) . It is characterized by chorea, psychiatric disturbances, and cognitive impairments . Although Exp-HTT is expressed ubiquitously in the brain, a selective vulnerability of striatal neurons, which is causal in the neuropathology, is now well established in the disease. The dopaminergic hypothesis of this vulnerability arose during the past years. First, the striatum receives the densest dopaminergic (DA) innervation of the brain, and striatal neurodegeneration in HD is positively correlated with the gradient of DA in its rostro-caudal extension (Vonsattel et al., 1985) . Second, in animal or cellular models, an exaggerated increase of DA produces spontaneous striatal death and HD-like behaviors (Luo et al., 1998; Cyr et al., 2003) . Furthermore, D2 receptor (D2R) stimulation by DA acts in synergy with Exp-HTT to increase aggregate formation, neuritic retraction, mitochondrial dysfunctions, and striatal death (Charvin et al., 2005; Benchoua et al., 2008) . In vivo, chronic treatment with the D2R antagonist haloperidol protects against striatal dysfunctions induced by Exp-HTT in a lentiviral-based model system in rats (Charvin et al., 2008) .
D2Rs belong to the structurally related G-protein-coupled receptors family, which are characterized by seven transmembrane segments (De Mei et al., 2009) . D2Rs are classically identified as inhibitors of cyclic AMP production and activation of PKA via their coupling to Gai subunits (De Mei et al., 2009 ). D2Rs also affect many downstream effectors including K+ channels (Greif et al., 1995) , L-type Ca 2+ channels and phospholipase C (PLC; Hernandez- Lopez et al., 2000) , glutamate release (Bamford et al., 2004; Yin & Lovinger, 2006) , and intracellular signaling pathways including mitogen-activated protein kinases and Akt (Brami-Cherrier et al., 2002; reviewed in Vallone et al., 2000; Neve et al., 2004) . We made the original observation that D2Rs were coupled to the Rho-ROCK signaling pathway, and that D2R-mediated activation of this pathway was responsible for a potentiation of ExpHTT-induced neuritic retraction and striatal neuron death (Deyts et al., 2009) .
Two variant transcripts are generated by alternative splicing of the D2Rs gene and code for the D2R Long and D2R Short isoforms, respectively (De Mei et al., 2009) . The D2R Short isoform differs from D2R Long by the deletion of 29 amino acids in the third intracellular loop of the receptor. These spliced variants are expressed in the same cell types and exhibit similar pharmacological characteristics with no isoform-specific pharmacological ligands identified so far. They possess a differential subcellular distribution, with D2R Short being preferentially presynaptic inhibitory autoreceptors and playing a preferential role in release modulation, (Lindgren et al., 2003) whereas D2R Long are predominantly postsynaptic receptors associated with G-protein-dependent and -independent intracellular signaling (De Mei et al., 2009) . Because D2R-induced potentiation of ExpHtt-induced striatal phenotype (aggregate formation and striatal death) was totally blocked by selective inhibition or knockdown of Rho-ROCK signaling pathway (Deyts et al., 2009 ), we investigated herein a possible specific coupling of D2R Short or D2R Long to the Rho/ROCK signaling pathway and striatal vulnerability in HD.
Materials and methods

HEK293 cell culture and transfection
HEK293 cells were cultured and maintained in Dulbecco's modified Eagle's medium (DMEM; Invitrogen, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum (FBS) and 0.1% penicillinstreptomycin. The day before transfection, the cells were plated in p100 mm dishes in DMEM without antibiotics. HEK293 cells were then transiently transfected using Lipofectamine (Invitrogen) with 4 lg of plasmids encoding N-terminal YFP-tagged D2 receptor isoforms, YFP-D2R Long and YFP-D2R Short (generously provided by Dr Philippe Vernier (CNRS, France) or empty plasmid during 24 h later.
Rho activity assay
Rho activation was analyzed using Rho assay kit (Upstate Biotechnology, Waltham, CA, USA). After overnight starvation in 0.1% FBS, HEK293 cells expressing D2R Short or D2R Long isoforms of D2R or the empty vector were stimulated with Quinpirole (10 lM, RBI) or Dopamine (DA; 100 lM, Calbiochem, San Diego, CA, USA) for 5 min at 37°C. Cells were then lysed in 10% glycerol, 50 mM Tris pH 7.2, 1% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS, 500 mM NaCl, 10 mM MgCl 2 , and complete protease inhibitor cocktail tablets (Roche, Indianapolis, IN, USA) for 15 min at 4°C in a rotator. Homogenates were clarified by centrifugation at 13 000 g at 4°C for 5 min. Rho activity was then measured according to the manufacturer's instructions. Rho-GTP was subjected to SDS-PAGE followed by western blotting with mouse anti-Rho (-A,-B,-C; 1/250; Millipore, Billerica, MA, USA). The bands were quantified by densitometric analysis using a dedicated macro application of SCION IMAGE software (Scion Corp., Frederick, MD, USA) and normalized to Total-Rho expression.
RNA interference
siRNAs were designed to interfere with the expression of both D2R isoforms (siRNA D2R Total: CCAGAGAGGACCCGGTAT) or only the D2R Long isoform (D2R Long siRNA: CCAGTGAA-CAGGCGGAGAA). Neurons were transfected at days in vitro (DIV4) with 50 nM of D2R Total siRNA, D2R Long-specific, or Control siRNA (Cont siRNA #2, Ambion, Austin, TX, USA). The specificity of siRNAs was validated in primary striatal cultures 72 h after transfection. When indicated, primary neurons were transfected (DIV7) with either wild-type (HTT) or expanded-HTT (Exp-HTT; see methods below). Drug treatment and evaluation of aggregates or death were performed as indicated above.
RNA isolation and RT-PCR
RNA isolation and RT-PCR methods were performed as previously described (Deyts et al., 2009) . The nucleotide sequences of the primers used to specifically amplify D2R Long and D2R Short receptors were as follows: D2R Long, forward 5 0 -AACTGTACC CACCCTGAGGA-3 0 , reverse 5 0 -GTTGCTATGTAGACCGTG-3 0 ; D2R Short, forward 5 0 -CACCACTCAAGGATGCTGCCCG-3 0 , reverse 5 0 -GTTGCTATGTAGACCGTG-3 0 . ARP (Acidic Ribosomal Protein) was used as a housekeeping gene: ARP, forward 5 0 -GAA CGTCGTCTTCGTGTTCA-3 0 , reverse 5 0 -AAAACCTGGACGAAG GAGGT-3 0 .
Primary striatal culture
Striatal neurons were dissected out from E14 embryos from pregnant Swiss mice (Janvier, France) as previously described (Charvin et al., 2005) and in accordance with the European Community guidelines on the Care and Use of Laboratory Animals (86/609/ EEC). Experiments were approved by the local ethic committee (reference 01435.02). For transfection assays, 0.8 lg of GFPtagged plasmids encoding the first exon of human Huntingtin (HTT) containing either 25 or 103 continuous CAA or CAG repeats (HTT and Exp-HTT, respectively) was transfected at DIV 7, using Lipofectamine (Invitrogen). Three hours and a half after transfection, the medium was removed and replaced by fresh culture medium containing DA (100 lM) or Quinpirole (10 lM).
Aggregate formation was evaluated 12 h after transfection by counting neurons expressing aggregated GFP vs. the total number of GFP-positive neurons. D2R agonist-induced potentiation of cell death was evaluated 24 h after transfection. Neurons containing condensed or fragmented nuclei, based on Hoechst labeling, were scored as dying cells.
Immunocytochemistry
Striatal neurons were fixed in 2% paraformaldehyde in PBS for 40 min at room temperature (RT) and permeabilized with methanol/ acetone (1 : 1) for 10 min at 4°C. After 1-h incubation with blocking buffer (10% normal goat serum in PBS, RT), cells were incubated overnight with primary antibodies in PBS at 4°C; mouse anti-MAP-2 (1/1000, Sigma Aldrich, St.Louis, MO, USA) or rabbit anti-P-cofilin (1/500, Cell Signaling, Technology, Ipswich, MA, USA). Cells were washed with PBS and incubated for 2 h at RT with corresponding Alexa-conjugated secondary antibodies (1/1000, Jackson Laboratories, Bar Harbor, Maine, USA). Nuclei were stained with Hoechst (1/20000 in PBS, Invitrogen). Coverslips were mounted using Mowiol (Calbiochem) and examined with a Leica DM4000B fluorescence microscope (209). In each experiment, conducted a minimum of three times, a total of at least 10 fields were randomly analyzed using IMAGEPRO-PLUS software.
Statistical analysis
Data are presented as mean AE SEM. Statistics were performed using GRAPHPAD PRISM (GraphPad Software Inc., San Diego, CA). One-way or two-way ANOVA followed by post hoc Bonferroni's test were carried out for statistical analyses as indicated in the results. The difference between comparisons was considered to be significant when P < 0.05.
Results
Overexpression of D2R Short, but not D2R Long, activates the RhoA/ROCK signaling in HEK293 cells
We previously showed that DA and the D2 agonist Quinpirole activate the RhoA/ROCK signaling pathway in primary cultures of striatal neurons (Deyts et al., 2009) . In order to investigate a possible differential coupling of either D2R Short or D2R Long to the RhoA/ ROCK signaling pathway, we first used a heterologous cellular system cDNAs encoding these D2R-specific isoforms tagged to YFP, were transfected in HEK293 cells, and allowed expression of the receptors that were trafficked to the plasma membrane, as expected ( Fig. 1A) . We next measured Rho activity by measuring RhoA-GTP levels relative to Total-RhoA in transfected cells ( Fig RhoA was activated by Quinpirole in D2R Short-expressing cells (P = 0.0028 between Control and Quinpirole-treated cells) but not D2R Long-expressing cells (P > 0.9999 non-significant between Control and Quinpirole-treated cells; Fig. 1B and D) . Similar results were obtained in DA-treated cells (P = 0.0292 between D2R Shortexpressing cells treated or not with Quinpirole; Fig. 1C and E) . In order to verify the functionality of the transfected D2Rs, ERK activation by Quinpirole was studied. As expected, a robust induction of ERKs phosphorylation was observed in response to Quinpirole in both D2R Short and D2R Long transfected cells (Fig. 1F) . These results clearly demonstrate a specific coupling of D2R Short but not D2R Long to RhoA activation in HEK293 cells.
siRNAs strategy for knocking down D2 receptors in striatal neurons in culture
We next designed a siRNA-based strategy aimed at silencing D2Rs expression in striatal neurons in culture. As a first step, we analyzed endogenous expression levels of mRNAs encoding D2R Short and D2R Long, in primary striatal neurons in culture (DIV 7 and DIV 15; Fig. 2A ). To amplify the D2R Long isoform, we used a forward primer annealing the exon 6, which is lost in D2R Short. To amplify D2R Short, the forward primer was designed in order to specifically bind to the spliced junction between exons 5 and 7. Reverse primers were designed to anneal with exon 7, common to both isoforms. RT-PCR showed that mRNAs encoding D2R Short and D2R Long were expressed in striatal neurons in culture (Fig. 2A) . Then we designed siRNAs in order to knockdown D2Rs (Fig. 2B) . D2R Total siRNA corresponded to a sequence of exon 7 common to both D2R Short and D2R Long mRNA sequences. The siRNA target sequence for specific knockdown of D2R Long mRNA was located in the exon 6, and thus absent in the D2R Short splice variant. Validation of these two siRNAs (D2R Total and D2R Long) was achieved after transfection in striatal neurons. As expected, semiquantitative RT-PCR showed that D2R Long siRNA knocked down D2R Long but not D2R Short expression (Fig. 2C) , while D2R Total siRNA decreased expression of both isoforms (Fig. 2D) . Quantifications showed that both D2R Long and D2R Total siRNAs decreased D2R Long mRNA levels when compared to Control (66%, P = 0.042 and 86.8%, P = 0.0003, respectively; Fig. 2E ), while D2R Short mRNA levels were significantly decreased after D2R Total siRNA treatment only (P = 0.0005; Fig. 2F ). We designed an siRNA targeting the spliced junction betweens exons 5 and 7, which failed to be efficient for the knowkdown of D2R Short (data not shown). Therefore, in the following experiments, we compared the effects of D2R Long and D2R Total siRNAs on D2R agonist and DA-induced RhoA/ROCK signaling in striatal neurons.
Comparative role of D2R Long siRNA and D2R Total siRNA in Quinpirole-induced phosphorylation of cofilin in striatal neurons
We previously showed that Quinpirole induces phosphorylation of cofilin, a downstream target of RhoA/ROCK signaling, and this phosphorylation event was totally reversed by ROCK inhibitors and siRNA against ROCKII (Deyts et al., 2009) . Thus, phosphorylated cofilin serves as an excellent index of ROCK activation to study D2Rs coupling to RhoA/ROCK pathway in striatal neurons. Striatal neurons were transfected at DIV4 for 72 h with D2R Total siRNA or D2R Long siRNA and stimulated or not with Quinpirole (10 lM, 20 min) or DA (not shown). The phosphorylation of cofilin was analyzed by immunocytochemical detection owing to a phospho-specific antibody. When transfected with the Control siRNA, striatal neurons showed a significant increase in phosphocofilin immunoreactivity after Quinpirole treatment (25% vs. 9% in untreated neurons; P = 0.001; Fig. 3A and D) . In striatal neurons transfected with D2R Long siRNA, Quinpirole induced a similar increase in phospho-cofilin immunoreactivity (23%; P = 0.0117 between Control and Quinpirole-treated cells; Fig. 3B and D) . However, knocking down both D2Rs isoforms using D2R Total siRNA completely blocked Quinpirole-induced cofilin phosphorylation (P = 0.0152 between Quinpirole-treated neurons expressing Control siRNA and D2R Total siRNA; Fig. 3C and D) . Altogether these results support that stimulation of D2R Short, but not D2R Long, is coupled to phosphorylation of cofilin in striatal neurons.
Comparative role of D2R Long siRNA and D2R Total siRNA on Quinpirole-induced potentiation of Exp-HTT toxicity and aggregate formation Using primary cultures of striatal neurons expressing exon 1 of HTT with a polyglutamine stretch (103Q: Exp-HTT) fused to EGFP, we previously showed that DA, via D2R stimulation, potentiates aggregate formation and striatal death induced by Exp-HTT (Charvin et al., 2005) . The RhoA/ROCK signaling pathway is critical for D2R-mediated effects on aggregate formation and neuronal death (Deyts et al., 2009) . We thus wished to compare the relative contribution of D2R Long and D2R Short in these effects. In striatal neurons transiently transfected with Exp-HTT, aggregate formation can be easily detectable owing to GFP Tag (Fig. 4A) . In neurons co-transfected with Exp-HTT together with the Control siRNA, a treatment with 10 lM of Quinpirole increased the percentage of transfected neurons containing aggregates (+36%; Fig. 4B ) and the D2R Long siRNA did not prevent this enhanced aggregation ( Fig. 4B ; P > 0.9999 non-significant between Control siRNA and D2R Long siRNA-treated cells). By contrast, the D2R Total siRNA reversed the potentiation of aggregate formation induced by Quinpirole ( Fig. 4B ; P = 0.0203), thus supporting a specific role of D2R Short on Quinpirole-mediated aggregation of Exp-HTT.
We next studied striatal death induced by Exp-HTT alone or in the presence of Quinpirole. Exp-HTT produced a significant striatal death (P = 0.0033 between untreated HTT and Exp-HTT-expressing cells), which was potentiated by Quinpirole (P = 0.0444 between Exp-HTT-expressing cells treated or not with Quinpirole; Fig. 4C ). D2R Long siRNA did not significantly affect the ratio of striatal death induced by ExpHTT in the presence of Quinpirole (P > 0.9999 non-significant; Fig. 4C ). By contrast, D2R Total siRNA completely reversed Quinpirole-induced toxicity in Exp-HTT-expressing neurons (P > 0.9999 non-significant between D2R Total siRNA cells treated or not with Quinpirole), thus supporting a preferential role of D2R-Short in this effect.
Comparative role effect of D2R Long siRNA and D2R Total siRNA on DA-induced potentiation of Exp-HTT aggregate formation and death When applied at high doses (500 lM), DA induces striatal death through a mechanism involving the formation of reactive oxygen species (ROS) formation and the activation of pro-apoptotic pathways (Luo et al., 1998) . This effect is accentuated with lower doses of DA (100 lM) in Exp-HTT-expressing cells (Charvin et al., 2005) , due to a dual role on ROS production (independent of DA receptors stimulation) and D2R stimulation. We analyzed the selective role of D2R Long siRNA and D2R Total siRNA in these effects. In Exp-HTT-expressing neurons, DA produced a significant increase in aggregate formation, which was not affected by D2R Long siRNA (P > 0.9999 non-significant between Control siRNA and D2R Long siRNA) but was completely abolished by D2R Total siRNA (P = 0.0106 between Control siRNA and D2R Total siRNA; Fig. 5A ). These data strongly suggest a role of D2R Short in DAmediated aggregate potentiation.
DA-induced striatal death was significantly higher in neurons overexpressing Exp-HTT than the wild-type HTT (P = 0.0035 between DA-treated HTT-expressing cells and DA-treated Exp-HTT-expressing cells; Fig. 5B ), thus illustrating the combined toxicity of DA and Exp-HTT. As previously shown, the total knockdown of D2R partially but significantly reversed this effect in Exp-HTTexpressing cells (P = 0.0419). The effect of DA was similar in DAtreated HTT and Exp-HTT-expressing cells in the presence of D2R Total siRNA (P > 0.9999 non-significant). Of interest, the toxicity induced by DA in Exp-HTT-expressing cells was not modified by D2R Long siRNA (P = 0.0144), data that confirm a specific role of D2R Short in DA-mediated toxicity (Fig. 5B) .
Discussion
In striatal neurons, we previously showed a coupling between D2R and the RhoA/ROCK signaling pathway (Deyts et al., 2009 ). Here we extend these observations and provide evidence for a specific coupling of D2R Short to this pathway, which affects striatal vulnerability to Exp-HTT.
Rho-associated kinases (ROCKs) are Ser/Thr protein kinases and downstream effectors of the small GTPases RhoA. They are important regulators of cell growth, migration, and apoptosis via the control of actin cytoskeletal assembly (for review Julian & Olson, 2014) . In the context of HD, it has been shown that inhibitors of ROCK decrease Exp-HTT aggregation formation (Burnett et al., 2008; Bauer et al., 2009 Bauer et al., , 2012 and activates the proteasome Data are expressed as mean AE SEM from three independent experiments (100 transfected neurons per condition and experiment). Statistical analyses were performed using two-way ANOVA followed by Bonferroni's post hoc analysis. ### P < 0.001; ## P < 0.005; # P < 0.05 when comparing untreated HTT and Exp-HTT-expressing cells. $$ P < 0.005 when comparing DA-treated HTT-and Exp-HTT-expressing cells. *P < 0.05, ***P < 0.001, when comparing Exp-HTT-expressing cells treated or not with DA. . Schematic representation of DA-mediated toxicity and striatal vulnerability in HD. During aging, DA auto-oxidation potentiates pro-apoptotic pathways that are activated by Exp-HTT (Charvin et al., 2005; Garcia et al., 2004) . By acting on D2R Short isoform, DA also activates the Rho/ROCK pathway, which potentiates Exp-HTT aggregate formation and neuronal death, two features of the pathogenesis of the disease. As a result, DA shows a dual implication in Exp-HTT-mediated toxicity. degradation pathways (Bauer et al., 2009 ). This pathway is significantly enriched in large-scale HTT-interacting protein networks and has been proposed as a modifier of Exp-HTT (Shirasaki et al., 2012; Tourette et al., 2014) . Rho/ROCK inhibition using pharmacological or molecular approaches reduces the aggregation and toxicity of proteins with expanded glutamine including HTT (Bauer et al., 2009 (Bauer et al., , 2012 , androgen receptor in drosophila, or cell line models (Pollitt et al., 2003) . Inhibition of Rho/ROCK pathway also shows benefits in Alzheimer disease (Hahmann & Schroeter, 2010; Li et al., 2013) as well as in other neurodegenerative diseases (for review Hensel et al., 2015) . Cofilin is a well-known substrate of Rho/ROCK pathway and is required for the actin cytoskeleton dynamics and reorganization of actin filaments (Bamburg & Wiggan, 2002) . Cofilin phosphorylation participates in neuronal dystrophy induced by beta-amyloid in Alzheimer's disease pathology (Heredia et al., 2006) . In striatal neurons in culture, the inhibition of ROCK reversed D2R-mediated phosphorylation of cofilin, along with Exp-HTT-induced aggregate formation, neuritic retraction, and neuronal death (Deyts et al., 2009) . Importantly, we show here that the coupling of D2R to RhoA/ROCK is specific of the Short, spliced version of D2R.
The molecular mechanisms at the origin of the D2R Shortmediated activation of Rho remain to be established. One candidate could be the scaffolding protein b-arrestin2, which facilitates some facets of D2R signaling, in addition to its canonical role in receptor internalization (Beaulieu et al., 2005) . Specific role of b-Arrestin2 in D2R Short, but not D2R Long-mediated ERK activation, has been described (Kim et al., 2004) . On the other hand, b-arrestins, which interact with the exchange factor for RhoGTPases PDZ-Rho-GEF (Oleksy et al., 2006) , are associated with the activation of Rho downstream the Angiotensin A2 receptors (Barnes et al., 2005) .
The first neuronal population affected in HD is the D2R expressing medium spiny neurons (MSNs; Roze et al., 2010) . In mice and human, neuropil aggregates appear first in the globus pallidus and the substantia nigra, two brain regions where D2R are enriched (Albin et al., 1992; Li et al., 2001) . Locally they are thought to be toxic by poisoning the axonal transport (Li et al., 2001; Lee et al., 2004) . Based on the present work, we propose that Exp-HTTinduced toxicity is exaggerated by DA via two routes (see Fig. 6 ): one involves auto-oxidation of DA (Luo et al., 1998) and potentiation of pro-apoptotic pathways that are activated by Exp-HTT (Garcia et al., 2004; Charvin et al., 2005) . The other one is associated with the stimulation of D2R Short isoform, which is coupled to the activation of the Rho-ROCK signaling pathway, the formation of aggregates, and neuronal death.
In addition to its important role in striatal vulnerability in HD, alterations of D2R-dependent signaling have been implicated in other brain pathologies such as schizophrenia, attention deficit hyperactivity disorder, Tourette syndrome, obsessive-compulsive disorder, Parkinson's disease, and drug addiction (Iversen & Iversen, 2007; Seeman, 2010) . The identification of D2Rs isoforms involved in these pathologies is of crucial importance for the development of new therapy. Herein, we provide evidence that interfering with D2R Short coupling to Rho might constitute a new and promising therapeutic strategy in HD and probably other brain pathologies.
